Skip to main content

Written question asked by Vincent Cable (Liberal Democrat) on Thursday, 8 May 2003, in the House of Commons. It was due for an answer on Monday, 19 May 2003. It was answered by Baroness Smith of Malvern (Labour) on Monday, 19 May 2003 on behalf of the Department of Health.


Dept of Health

Question
To ask the Secretary of State for Health, what targets he has to increase awareness of myalgic encephalomyelitis; and if he will make a statement; if he will make a statement on regional variations in the incidence of myalgic encephalomyelitis. - Inc figures and ref to the report of the Independent Working Group January 2002.
Answer

Dr. Cable: To ask the Secretary of State for Health (1) what targets he has to increase awareness of myalgic encephalomyelitis; and if he will make a statement; [113044] (2) if he will make a statement on regional variations in the incidence of myalgic encephalomyelitis. [113045] Jacqui Smith: We helped raise awareness of chronic fatigue syndrome (CFS), which is also known as myalgic encephalomyelitis (ME), by publishing the report of the Independent Working Group in January 2002. In October 2002, we made the national health service aware, through the "Chief Executive's Bulletin" and the "GP Bulletin", of the guidance produced by Action for ME called "Guidance on the Management of CFS/ ME". On 12 May 2003, I announced that £8.5 million would be made available for services specifically designed for people with CFS/ME. The funding will be used to develop services for people with CFS/ME. In July, health organisations will be invited to bid for development funds to set up centres of expertise to develop clinical care, support clinical research and expand education and training programmes for health care professionals and to establish satellite community multidisciplinary teams. The first phase of development will commence in April 2004. Information on the prevalence of individual conditions is not collected centrally. The report of the independent CFS/ME working group, published in January 2002, estimated a population prevalence of around 0.2-0.4 per cent. in adults and around 0.07 per cent. in children. They made no analysis of regional variations.


Secondary information

Type
Written question
Reference
405 c610W;405 c608W; 113044;113045
Session
2002-03
Subjects
ME/CFS Health education
Contains statistics
Yes
Link
View this Written question on www.publications.parliament.uk